Anika Therapeutics Inc. Stock News

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company, today announced that Cheryl R. Blanchard, Ph.D., President and Chief Executive Offi

Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation and regenerative therapies company, today announced that Cheryl R. Bl

Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2020 Results Earnings Conference Call May 07, 2020, 05:00 PM ET Company Participants Sylvia Cheung - Chief Financial O

With me on the call today is Dr. Cheryl Blanchard, who was recently appointed President and Chief Executive Officer of Anika. During today's call, Cheryl and I will review our first quarter 2020 fina

Anika (ANIK) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank 2 (Buy).

The osteoarthritis therapeutics market size has the potential to grow by USD 2.99 billion during 2020-2024

Total Revenue Increases 43% Year-over-YearContinued Progress on Integration of Parcus Medical and Arthrosurface AcquisitionsWithdrawing Full Year 2020 Financial Guidance Well.

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs May 6.) Adverum Biotechnologies Inc...

Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...

Anyone researching Anika Therapeutics, Inc. (NASDAQ:ANIK) might want to consider the historical volatility of the...

Anika (ANIK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Anika (ANIK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Anika Therapeutics (NASDAQ:ANIK) will be issuing its quarterly earnings data after the market closes on Thursday, May 7th. Analysts expect the company to announce earnings of $0.40 per share for the q

Dublin, April 30, 2020 -- The "Global Wound Care Biologics Market 2019-2025" report has been added to ResearchAndMarkets.com's offering. The global wound.

BBVA USA Bancshares Inc. lifted its holdings in shares of Anika Therapeutics Inc (NASDAQ:ANIK) by 2.5% in the 1st quarter, Holdings Channel reports. The institutional investor owned 17,807 shares of t